title: Evaluation of state-provided postexposure prophylaxis against rabies in Florida.
abstract: BACKGROUND
  One key component of human rabies prevention is the use of postexposure prophylaxis (PEP). No information is routinely available to evaluate the appropriateness of this intervention.
  
  
  METHODS
  A survey queried county health departments regarding rabies PEP administered during July through September in 1997 and in 1998.
  
  
  RESULTS
  A total of 160 cases meeting the study criteria were characterized. Domestic animals accounted for most potential rabies exposures. Nearly a quarter of the reports indicated that PEP was not necessary. Health departments collected just over 25% of costs for antirabies biologics.
  
  
  CONCLUSIONS
  Human rabies prevention systems can be enhanced by reducing the number of PEP events through improved recovery of biting animals. Inappropriate administration of PEP and cost can be reduced by establishing a system of after-the-fact review of every episode of PEP with timely feedback to providers.
authors.affiliation: Florida Department of Health, Tallahassee, USA.
authors.forename: Lisa
authors.initials: L
authors.lastname: Conti
authors.forename: Steven
authors.initials: S
authors.lastname: Wiersma
authors.forename: Richard
authors.initials: R
authors.lastname: Hopkins
mesh_terms: D000293:Adolescent; D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D000818:Animals; D000829:Animals, Domestic / Q000821:virology; D001733:Bites and Stings / Q000453:epidemiology / Q000821:virology; D002648:Child; D002675:Child, Preschool; D004199:Disease Vectors; D005260:Female; D005431:Florida / Q000453:epidemiology; D017048:Health Care Costs; D006801:Humans; D007136:Immunoglobulins / Q000627:therapeutic use; D007223:Infant; D007349:Insurance, Health, Reimbursement; D008297:Male; D008875:Middle Aged; D018579:Patient Selection; D011292:Premedication; D011314:Preventive Health Services / Q000191:economics / Q000706:statistics & numerical data; D011635:Public Health Administration; D011787:Quality of Health Care; D011818:Rabies / Q000453:epidemiology / Q000517:prevention & control* / Q000635:transmission; D011819:Rabies Vaccines / Q000627:therapeutic use*
chemical_list: D007136:Immunoglobulins; D011819:Rabies Vaccines